文献速递产科母胎医学

足月临床绒毛膜羊膜炎:定义、发病机制、微生物学、诊断与治疗

Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment.
PubMed 文献 · Am J Obstet Gynecol · 2023-03-21

本文综述足月临床绒毛膜羊膜炎的定义、发病机制、微生物学、诊断与治疗。该综合征可由羊膜腔内感染、无菌性羊膜腔内炎症或硬膜外镇痛引起的母体全身炎症所致,羊水中检测细菌与炎症标志物可确诊,产时抗生素是标准治疗以降低新生儿脓毒症。

要点

  • 临床绒毛膜羊膜炎是产时发热伴至少两项母胎炎症体征的综合征,病因包括羊膜腔内感染、无菌性炎症及硬膜外镇痛相关全身炎症。
  • 最常见微生物为脲原体属,70%病例为多种微生物混合感染,新生儿血培养阳性率为0.2%至4%。
  • 产时使用氨苄西林与庆大霉素是专业学会推荐的降低新生儿脓毒症的标准治疗,也可考虑使用阿奇霉素或克拉霉素等覆盖脲原体属的抗菌药物。

核心结论

  • 临床绒毛膜羊膜炎是产时发热伴母胎炎症体征的综合征,可由羊膜腔内感染、无菌性羊膜腔内炎症或硬膜外镇痛引起的母体全身炎症导致,产时抗生素是降低新生儿脓毒症的标准治疗。

研究设计与样本

  • 本文为综述,围绕足月临床绒毛膜羊膜炎的定义、发病机制、微生物学、诊断与治疗进行阐述。

主要发现

  • 临床绒毛膜羊膜炎在产时发热伴至少两项母胎局部或全身炎症体征(如母体心动过速、子宫压痛、母体白细胞增多、阴道分泌物或羊水异味、胎儿心动过速)时被怀疑。
  • 羊膜腔内感染最常见微生物为脲原体属,70%病例为多种微生物混合感染,新生儿血培养阳性率范围为0.2%至4%。
  • 临床绒毛膜羊膜炎与子宫收缩力减弱、产程停滞及产后出血相关,但本身并非剖宫产指征。
  • 足月附近患临床绒毛膜羊膜炎母亲所生婴儿有早发型新生儿脓毒症和远期残疾(如脑性瘫痪)风险。

关键数值与推荐

  • 羊水分析可通过检测细菌(革兰染色、培养或微生物核酸检测)和炎症(白细胞计数、葡萄糖浓度、白细胞介素-6、白细胞介素-8、基质金属蛋白酶-8)来明确诊断。
  • 产时使用氨苄西林与庆大霉素已被专业学会推荐,其他抗生素方案如头孢菌素类也曾被使用。
  • 鉴于脲原体属是羊膜腔内感染的重要病因,需要考虑使用对这类微生物有效的抗菌药物如阿奇霉素或克拉霉素。
  • 本研究中心已使用头孢曲松、克拉霉素与甲硝唑联合方案,微生物学研究显示该方案可根除羊膜腔内感染。
  • 对受累母亲所生新生儿常规检测生殖支原体可提高新生儿脓毒症的检出。

临床怎么用

  • 产时给予抗生素是降低新生儿脓毒症的标准治疗,推荐方案为氨苄西林与庆大霉素,其他方案如头孢菌素类也曾被使用。
  • 鉴于脲原体属的重要性,需要考虑使用阿奇霉素或克拉霉素等有效药物;本研究中心已使用头孢曲松、克拉霉素与甲硝唑联合方案。
  • 临床绒毛膜羊膜炎本身不是剖宫产指征,常使用缩宫素加强宫缩,应备好宫缩剂处理产后出血。
  • 对受累母亲所生新生儿常规检测生殖支原体可提高新生儿脓毒症的检出。
  • 经宫颈羊水采集器联合IL-8快速床旁检测的无创羊水评估是诊断羊膜腔内炎症的前沿方向,有望提高诊断准确性并为抗菌药物使用提供依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical chorioamnionitis, the most common infection-related diagnosis in labor and delivery units, is an antecedent of puerperal infection and neonatal sepsis. The condition is suspected when intrapartum fever is associated with two other maternal and fetal signs of local or systemic inflammation (eg, maternal tachycardia, uterine tenderness, maternal leukocytosis, malodorous vaginal discharge or amniotic fluid, and fetal tachycardia). Clinical chorioamnionitis is a syndrome caused by intraamniotic infection, sterile intraamniotic inflammation (inflammation without bacteria), or systemic maternal inflammation induced by epidural analgesia. In cases of uncertainty, a definitive diagnosis can be made by analyzing amniotic fluid with methods to detect bacteria (Gram stain, culture, or microbial nucleic acid) and inflammation (white blood cell count, glucose concentration, interleukin-6, interleukin-8, matrix metalloproteinase-8). The most common microorganisms are Ureaplasma species, and polymicrobial infections occur in 70% of cases. The fetal attack rate is low, and the rate of positive neonatal blood cultures ranges between 0.2% and 4%. Intrapartum antibiotic administration is the standard treatment to reduce neonatal sepsis. Treatment with ampicillin and gentamicin have been recommended by professional societies, although other antibiotic regimens, eg, cephalosporins, have been used. Given the importance of Ureaplasma species as a cause of intraamniotic infection, consideration needs to be given to the administration of antimicrobial agents effective against these microorganisms such as azithromycin or clarithromycin. We have used the combination of ceftriaxone, clarithromycin, and metronidazole, which has been shown to eradicate intraamniotic infection with microbiologic studies. Routine testing of neonates born to affected mothers for genital mycoplasmas could improve the detection of neonatal sepsis. Clinical chorioamnionitis is associated with decreased uterine activity, failure to progress in labor, and postpartum hemorrhage; however, clinical chorioamnionitis by itself is not an indication for cesarean delivery. Oxytocin is often administered for labor augmentation, and it is prudent to have uterotonic agents at hand to manage postpartum hemorrhage. Infants born to mothers with clinical chorioamnionitis near term are at risk for early-onset neonatal sepsis and for long-term disability such as cerebral palsy. A frontier is the noninvasive assessment of amniotic fluid to diagnose intraamniotic inflammation with a transcervical amniotic fluid collector and a rapid bedside test for IL-8 for patients with ruptured membranes. This approach promises to improve diagnostic accuracy and to provide a basis for antimicrobial administration.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Jung E, Romero R, Suksai M, et al. Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment. Am J Obstet Gynecol. 2023. PMID: 38233317. doi:10.1016/j.ajog.2023.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。